<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Fungi (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">J Fungi (Basel)</journal-id><journal-id journal-id-type="publisher-id">jof</journal-id><journal-title-group><journal-title>Journal of Fungi</journal-title></journal-title-group><issn pub-type="epub">2309-608X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8537117</article-id><article-id pub-id-type="doi">10.3390/jof7100849</article-id><article-id pub-id-type="publisher-id">jof-07-00849</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Selection of <italic toggle="yes">Pneumocystis jirovecii</italic> Inosine 5&#x02032;-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hoffmann</surname><given-names>Claire V.</given-names></name><xref rid="af1-jof-07-00849" ref-type="aff">1</xref><xref rid="af2-jof-07-00849" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Nevez</surname><given-names>Gilles</given-names></name><xref rid="af1-jof-07-00849" ref-type="aff">1</xref><xref rid="af2-jof-07-00849" ref-type="aff">2</xref><xref rid="c1-jof-07-00849" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Moal</surname><given-names>Marie-Christine</given-names></name><xref rid="af3-jof-07-00849" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Quinio</surname><given-names>Doroth&#x000e9;e</given-names></name><xref rid="af1-jof-07-00849" ref-type="aff">1</xref><xref rid="af2-jof-07-00849" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Le Nan</surname><given-names>Nathan</given-names></name><xref rid="af2-jof-07-00849" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6265-7321</contrib-id><name><surname>Papon</surname><given-names>Nicolas</given-names></name><xref rid="af4-jof-07-00849" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Bouchara</surname><given-names>Jean-Philippe</given-names></name><xref rid="af4-jof-07-00849" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8913-415X</contrib-id><name><surname>Le Meur</surname><given-names>Yannick</given-names></name><xref rid="af3-jof-07-00849" ref-type="aff">3</xref><xref rid="af5-jof-07-00849" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Le Gal</surname><given-names>Sol&#x000e8;ne</given-names></name><xref rid="af1-jof-07-00849" ref-type="aff">1</xref><xref rid="af2-jof-07-00849" ref-type="aff">2</xref><xref rid="c1-jof-07-00849" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Calder&#x000f3;n</surname><given-names>Enrique J.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Miller</surname><given-names>Robert F.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>de Armas</surname><given-names>Yaxsier</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jof-07-00849"><label>1</label>Laboratoire de Parasitologie et Mycologie, H&#x000f4;pital de La Cavale Blanche, CHU de Brest, 29609 Brest, France; <email>hoffmann.claire@neuf.fr</email> (C.V.H.); <email>dorothee.quinio@chu-brest.fr</email> (D.Q.)</aff><aff id="af2-jof-07-00849"><label>2</label>Groupe d&#x02019;Etude des Interactions H&#x000f4;te-Pathog&#x000e8;ne (GEIHP), Universit&#x000e9; d&#x02019;Angers, Universit&#x000e9; de Brest, 29238 Brest, France; <email>nathan.lenan@univ-brest.fr</email></aff><aff id="af3-jof-07-00849"><label>3</label>D&#x000e9;partement de N&#x000e9;phrologie, CHU de Brest, 29609 Brest, France; <email>marie-christine.moal@chu-brest.fr</email> (M.-C.M.); <email>yannick.lemeur@chu-brest.fr</email> (Y.L.M.)</aff><aff id="af4-jof-07-00849"><label>4</label>Groupe d&#x02019;Etude des Interactions H&#x000f4;te-Pathog&#x000e8;ne (GEIHP), Universit&#x000e9; de Brest, Universit&#x000e9; d&#x02019;Angers, 49035 Angers, France; <email>nicolas.papon@univ-angers.fr</email> (N.P.); <email>jean-philippe.bouchara@univ-angers.fr</email> (J.-P.B.)</aff><aff id="af5-jof-07-00849"><label>5</label>UMR1227, Lymphocytes B et Autoimmunit&#x000e9;, Universit&#x000e9; de Brest, Inserm, Labex IGO, 20609 Brest, France</aff><author-notes><corresp id="c1-jof-07-00849"><label>*</label>Correspondence: <email>gilles.nevez@chu-brest.fr</email> (G.N.); <email>solene.legal@chu-brest.fr</email> (S.L.G.); Tel.: +33-(0)-2-98-14-51-02 (G.N. &#x00026; S.L.G.); Fax: +33-(0)-2-98-14-51-49 (G.N. &#x00026; S.L.G.)</corresp></author-notes><pub-date pub-type="epub"><day>10</day><month>10</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2021</year></pub-date><volume>7</volume><issue>10</issue><elocation-id>849</elocation-id><history><date date-type="received"><day>15</day><month>9</month><year>2021</year></date><date date-type="accepted"><day>06</day><month>10</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Mycophenolic acid (MPA) targets the inosine 5&#x02032;-monophosphate dehydrogenase (IMPDH) of human lymphocytes. It is widely used as an immunosuppressant to prevent rejection in solid organ transplant (SOT) recipients who, incidentally, are at risk for <italic toggle="yes">Pneumocystis</italic> pneumonia (PCP). We hypothesized that MPA exerts selective pressure on <italic toggle="yes">P. jirovecii</italic> microorganisms considering its in vitro antifungal activity on other fungi. Thus, we analysed <italic toggle="yes">impdh</italic> gene in <italic toggle="yes">P. jirovecii</italic> isolates from SOT recipients. <italic toggle="yes">P. jirovecii</italic> specimens from 26 patients diagnosed with PCP from 2010 to 2020 were retrospectively examined: 10 SOT recipients treated with MPA and 16 non-SOT patients without prior exposure to MPA. The <italic toggle="yes">P. jirovecii impdh</italic> gene was amplified and sequenced. Nucleotide sequences were aligned with the reference sequences retrieved from available <italic toggle="yes">P. jirovecii</italic> whole genomes. The deduced IMPDH protein sequences were aligned with available IMPDH proteins from <italic toggle="yes">Pneumocystis</italic> spp. and other fungal species known to be in vitro sensitive or resistant to MPA. A total of nine SNPs was identified. One SNP (G1020A) that results in an Ala261Thr substitution was identified in all SOT recipients and in none of the non-SOT patients. Considering that IMPDHs of other fungi, resistant to MPA, harbour Thr (or Ser) at the analogous position, the Ala261Thr mutation observed in MPA-treated patients was considered to represent the signature of <italic toggle="yes">P. jirovecii</italic> exposure to MPA. These results suggest that MPA may be involved in the selection of specific <italic toggle="yes">P. jirovecii</italic> strains that circulate in the SOT recipient population.</p></abstract><kwd-group><kwd><italic toggle="yes">Pneumocystis jirovecii</italic></kwd><kwd>IMPDH</kwd><kwd>transplantation</kwd><kwd>selection</kwd><kwd>mycophenolic acid</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-jof-07-00849"><title>1. Introduction</title><p><italic toggle="yes">Pneumocystis jirovecii</italic> (<italic toggle="yes">P. jirovecii</italic>) is a transmissible, uncultivable fungus responsible for severe pneumonia in immunosuppressed patients. <italic toggle="yes">Pneumocystis</italic> pneumonia (PCP) remains the most frequent AIDS defining infection in HIV-infected patients in developed countries. In France, PCP represents 30% of the annually reported 1200 AIDS cases [<xref rid="B1-jof-07-00849" ref-type="bibr">1</xref>]. PCP also affects immunosuppressed patients not infected with HIV [<xref rid="B2-jof-07-00849" ref-type="bibr">2</xref>,<xref rid="B3-jof-07-00849" ref-type="bibr">3</xref>]. PCP occurs in 5&#x02013;15% of solid organ transplant (SOT) recipients in the absence of prophylaxis, with a mortality rate up to 49% [<xref rid="B4-jof-07-00849" ref-type="bibr">4</xref>,<xref rid="B5-jof-07-00849" ref-type="bibr">5</xref>]. The frequency of PCP seems to increase in SOT recipients, specifically in renal transplant recipients (RTR), particularly when the transplantation is not recent, when the patients are no longer subjected to PCP prophylaxis and when the acquisition of <italic toggle="yes">P. jirovecii</italic> is nosocomial [<xref rid="B6-jof-07-00849" ref-type="bibr">6</xref>].</p><p>Mycophenolic acid (MPA) is a widely used anti-rejection treatment included in immunosuppressive regimens for SOT recipients. It targets the inosine 5&#x02032;-monophosphate dehydrogenase (IMPDH), an enzyme involved in de novo purine nucleotide biosynthesis. MPA specifically inhibits the proliferation of B and T lymphocytes, since these cells synthesize de novo purines while other human cells can use alternate pathways for this synthesis [<xref rid="B7-jof-07-00849" ref-type="bibr">7</xref>]. Therefore, MPA is a powerful immunosuppressive drug. The resulting immunosuppression leads to opportunistic infection occurrence [<xref rid="B8-jof-07-00849" ref-type="bibr">8</xref>]. Nevertheless, data on the occurrence of PCP in patients treated with MPA are contradictory. MPA may have an antifungal activity on <italic toggle="yes">Pneumocystis</italic>. Oz and Hughes used a rat model which demonstrated that none of the animals treated with MPA alone or in association with dexamethasone developed PCP whereas 90% of rats treated with dexamethasone or tacrolimus alone developed PCP after 4 weeks of treatment [<xref rid="B9-jof-07-00849" ref-type="bibr">9</xref>]. Husain and Singh showed that PCP frequency in RTR treated with MPA was significantly lower than in RTRs without MPA treatment (0/1068 vs. 10/563, <italic toggle="yes">p</italic> = 0.00006) [<xref rid="B8-jof-07-00849" ref-type="bibr">8</xref>]. On the other hand, we have published three series of PCP case clusters in RTR and heart transplant recipients (HTR) and noted the occurrence of 38 PCP cases in patients effectively treated with MPA [<xref rid="B10-jof-07-00849" ref-type="bibr">10</xref>,<xref rid="B11-jof-07-00849" ref-type="bibr">11</xref>,<xref rid="B12-jof-07-00849" ref-type="bibr">12</xref>]. Considering these aforementioned observations, the putative antifungal activity of MPA on <italic toggle="yes">P. jirovecii</italic> remains a subject of debate. Conversely, MPA is known to have an in vitro antifungal activity on other fungal species which is useful in fundamental mycology [<xref rid="B13-jof-07-00849" ref-type="bibr">13</xref>].</p><p>The emergence of pathogen strains under selection pressure is widespread in microbiology and also observed for <italic toggle="yes">P. jirovecii</italic> [<xref rid="B11-jof-07-00849" ref-type="bibr">11</xref>,<xref rid="B14-jof-07-00849" ref-type="bibr">14</xref>]. In this context, the hypothesis of the emergence of particular genotypes/phenotypes of <italic toggle="yes">P. jirovecii</italic> under MPA selection pressure is relevant. The objective of the present study was to investigate this field and we retrospectively sequenced the <italic toggle="yes">impdh</italic> gene of <italic toggle="yes">P. jirovecii</italic> isolates from SOT recipients treated with MPA and a control group of non-SOT recipients with no prior exposure to MPA.</p></sec><sec sec-type="methods" id="sec2-jof-07-00849"><title>2. Methods</title><sec id="sec2dot1-jof-07-00849"><title>2.1. Hospital Settings</title><p>Brest University hospital is a 2500-bed healthcare facility, characterized by 460,000 outpatient visits and 120,000 inpatients monitored per year. Specialized care is provided for about 550 renal transplant recipients.</p></sec><sec id="sec2dot2-jof-07-00849"><title>2.2. Patients and P. jirovecii Specimens</title><p>Twenty-six <italic toggle="yes">P. jirovecii</italic> specimens from 26 patients diagnosed with PCP, between 2010 and 2020, were retrospectively examined. They consisted of one group of 10 SOT recipients (T1 to T10) (sex ratio M/F 7/3; median age 65 years (55&#x02013;78 years)) and another group of 16 patients who were not transplant recipients (C1 to C16) (sex ratio M/F 12/4; median age 60 years (30&#x02013;89 years)). The first group had undergone MPA treatment since the day of transplantation, with a median duration of exposure of 51 months (range: 8&#x02013;216 months) conversely to the second group who did not have any prior exposure to MPA (control group). Patient characteristics are summarized in <xref rid="jof-07-00849-t001" ref-type="table">Table 1</xref> and <xref rid="jof-07-00849-t002" ref-type="table">Table 2</xref>. Biological diagnoses of PCP were initially based on microscopic detection of <italic toggle="yes">P. jirovecii</italic> and/or DNA amplification using a qPCR assay targeting the gene encoding the mitochondrial large subunit of ribosomal RNA which was performed after DNA extraction using NucliSens easyMag (bio-M&#x000e9;rieux, France) as we previously described [<xref rid="B15-jof-07-00849" ref-type="bibr">15</xref>]. <italic toggle="yes">P. jirovecii</italic> DNA specimens were stored at &#x02212;80 &#x000b0;C for further analysis. The study was non-interventional and did not require inform consents and ethical approval according to French laws and regulations (CSP Art L1121e1.1). Specimen collection was registered with the French Ministry of Research (No. DC-2008-214).</p></sec><sec id="sec2dot3-jof-07-00849"><title>2.3. P. jirovecii IMPDH Gene Analysis</title><p>The IMPDH protein of <italic toggle="yes">Pneumocystis carinii</italic> (the rat-derived <italic toggle="yes">Pneumocystis</italic> species) (NCBI accession number AAA97462.1) [<xref rid="B16-jof-07-00849" ref-type="bibr">16</xref>] was used as the query sequence in a BLASTp search against <italic toggle="yes">P. jirovecii</italic> proteomes at <uri xlink:href="https://www.uniprot.org/blast/">https://www.uniprot.org/blast/</uri> (accessed on 14 September 2021). A single putative ortholog was detected in each proteome available, i.e., one ortholog (UniProt identifier A0A0W4ZU90) in the proteome from Ma and colleagues (BioProject PRJNA223510) [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>] and one ortholog (UniProt identifier L0P7N3) in the proteome from Cisse and colleagues (BioProject PRJEA68827) [<xref rid="B18-jof-07-00849" ref-type="bibr">18</xref>]. The <italic toggle="yes">P. jirovecii</italic> gene sequences encoding the IMPDH protein were then retrieved from the European Nucleotide Archive (<uri xlink:href="http://www.ebi.ac.uk/ena">http://www.ebi.ac.uk/ena</uri>, accessed on 14 September 2021). The <italic toggle="yes">impdh</italic> gene corresponds to the T551_00631 locus in the <italic toggle="yes">P.jirovecii</italic> genome assembly version Pneu-jiro_RU7_V2 (BioProject PRJNA223510) [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>] and to the PNEJI1_002926 locus in the <italic toggle="yes">P.jirovecii</italic> genome assembly version ASM33397v2 (BioProject PRJEA68827) [<xref rid="B18-jof-07-00849" ref-type="bibr">18</xref>].</p><p>Six primer pairs were designed using PrimerQuest&#x000a9; software (Integrated DNA Technology, <uri xlink:href="https://www.idtdna.com/Primerquest/Home/Index">https://www.idtdna.com/Primerquest/Home/Index</uri>, accessed on 14 September 2021) in order to sequence the whole <italic toggle="yes">IMPDH</italic> gene, which is 2070 bp long. Primer specificity was checked using Basic Local Alignment Search Tool (<uri xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">https://blast.ncbi.nlm.nih.gov/Blast.cgi</uri>, accessed on 14 September 2021). Each primer pair amplifies a DNA fragment from 376 to 915 bp in size (<xref rid="app1-jof-07-00849" ref-type="app">Table S1</xref>). Each fragment partially spanned at least one other fragment (<xref rid="app1-jof-07-00849" ref-type="app">Figure S1</xref>). The six fragments of the <italic toggle="yes">impdh</italic> gene were amplified under the same PCR conditions. PCR reactions were performed in a final volume of 50 &#x000b5;L containing 0.5 &#x000b5;M of reverse and forward primers, 3 mM MgCl<sub>2</sub>, 200 &#x000b5;M dNTPs (dNTP set, Eurogentec, Belgium) and 2 U of polymerase (HotGoldStar Diamond Taq<sup>&#x000ae;</sup>, Eurogentec, Belgium). Amplification was carried out with activation step at 95 &#x000b0;C for 10 min followed by 45 cycles including denaturation at 94 &#x000b0;C for 30 s, annealing at 60 &#x000b0;C for 45 s and extension at 72 &#x000b0;C for 1 min and a final extension step at 72 &#x000b0;C for 10 min. To avoid contamination, reagent preparations and amplification procedures were performed in separate rooms with different sets of micropipettes. Negative control was included in each PCR. PCR products were electrophoresed on 1.5% agarose gel containing ethidium bromide to visualize the expected band sizes (<xref rid="app1-jof-07-00849" ref-type="app">Table S1</xref>). PCR products were purified and sequenced from the two strands with the dideoxy chain termination method on the ABI 3130XL Genetic Analyzer (BigDye<sup>&#x000ae;</sup> terminator v1.1 cycle sequencing kit, Applied Biosystem, USA). Electropherograms were analysed using PreGap and Gap software (Staden package version 2.0.0b11-2016, Staden Group). The six fragments were assembled to create the consensus sequence of the <italic toggle="yes">impdh</italic> gene from each specimen. Nucleotide and protein sequences were aligned with the reference sequences retrieved from complete <italic toggle="yes">P. jirovecii</italic> genomes as described above using BioEdit software (Version 7.0.0, Thomas Hall, Ibis Biosciences, USA) with the Clustal<sup>&#x000ae;</sup>W program. The identification of putative <italic toggle="yes">IMPDH</italic> alleles was based on the single nucleotide polymorphisms (SNPs).</p><p>Sequence logos were created using Weblogo application (<uri xlink:href="https://weblogo.berkeley.edu/logo.cgi">https://weblogo.berkeley.edu/logo.cgi</uri>, accessed on 14 September 2021) [<xref rid="B19-jof-07-00849" ref-type="bibr">19</xref>].</p><p>The deduced IMPDH protein sequences of <italic toggle="yes">P. jirovecii</italic> were aligned with available IMPDH protein sequences of <italic toggle="yes">Pneumocystis carinii</italic> (Uniprot identifier A0A0W4ZEI8), <italic toggle="yes">Pneumocystis murina</italic> (Uniprot identifier M7NKD5), <italic toggle="yes">Candida albicans</italic> (Uniprot identifier Q59Q46 and GenBank accession number AAW65379.1), <italic toggle="yes">Meyerozyma guilliermondii</italic> (Uniprot identifiers A5DL50 and A5DLR4), <italic toggle="yes">Saccharomyces cerevisiae</italic> (Uniprot identifiers P38697 and P50095), <italic toggle="yes">Penicillium brevicompactum</italic> (Uniprot identifier G4WT15) and <italic toggle="yes">Aspergillus nidulans</italic> (Aspergillus Genome Database identifier AN12478) using T-coffee [<xref rid="B20-jof-07-00849" ref-type="bibr">20</xref>]. These protein sequences were retrieved from Uniprot, GenBank and Aspergillus Genome databases (<xref rid="app1-jof-07-00849" ref-type="app">Table S2</xref>).</p></sec><sec id="sec2dot4-jof-07-00849"><title>2.4. Statistical Analysis</title><p>Frequencies of <italic toggle="yes">P. jirovecii IMPDH</italic> alleles and potential mixed infections, which were defined by the presence of more than one allele in the same specimen, were compared in the two patient groups using Fisher&#x02019;s exact test. A <italic toggle="yes">p</italic> value of &#x0003c;0.05 was considered significant.</p></sec><sec id="sec2dot5-jof-07-00849"><title>2.5. Nucleotide Sequence Accession Number</title><p>The nucleotide sequences of the <italic toggle="yes">impdh</italic> gene obtained in the present study have been deposited in GenBank under accession numbers from MZ272376 to MZ272401.</p></sec></sec><sec sec-type="results" id="sec3-jof-07-00849"><title>3. Results</title><p>A single IMPDH protein was identified within each of the two available <italic toggle="yes">P. jirovecii</italic> proteomes by a search of homology with the IMPDH protein of <italic toggle="yes">P. carinii</italic>. The two <italic toggle="yes">P. jirovecii impdh</italic> gene sequences were identical, except two synonymous SNPs at positions 1850 and 1952 (<xref rid="app1-jof-07-00849" ref-type="app">Figure S2</xref>). The <italic toggle="yes">P. jirovecii impdh</italic> gene is 2070 bp long, encompassing eight introns. The six fragments of the <italic toggle="yes">impdh</italic> gene were successfully amplified using the six designed primer pairs and afterward sequenced in all 26 patients. Consensus sequences of the <italic toggle="yes">P. jirovecii impdh</italic> gene were compared to the <italic toggle="yes">impdh</italic> gene sequence from <italic toggle="yes">P. jirovecii</italic> genome assembly version Pneu-jiro_RU7_V2 (T551_00631 locus), which was used as a reference sequence to identify SNPs [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>]. Nine SNPs were identified at positions 76 (G76T), 914 (G914A), 1020 (G1020A), 1269 (C1269T), 1329 (A1329T), 1737 (G1737A), 1754 (C1754T), 1850 (T1850C) and 1952 (G1952A) (<xref rid="app1-jof-07-00849" ref-type="app">Figure S2</xref>; <xref rid="app1-jof-07-00849" ref-type="app">Figure S3</xref>; <xref rid="jof-07-00849-t003" ref-type="table">Table 3</xref>). SNP at positions 1020, 1269, 1329, 1737, 1754, 1850 and 1952 were found in at least two patients each (<xref rid="jof-07-00849-t003" ref-type="table">Table 3</xref>). SNP at positions 76 and 914 were found in only one patient each (G76T in C10 and G914A in C13) and were confirmed with a second PCR-sequencing experiment. Eight putative <italic toggle="yes">IMPDH</italic> alleles were defined based on these polymorphisms (<xref rid="jof-07-00849-t004" ref-type="table">Table 4</xref>). The sequence of the <italic toggle="yes">impdh</italic> gene from Ma and colleagues (T551_00631 locus) [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>] corresponds to allele <italic toggle="yes">IMPDH-1</italic>. This allele was identified in two SOT recipients (T3 and T9) and four control patients (C1, C8, C14 and C15). The sequence of the <italic toggle="yes">impdh</italic> gene from Ciss&#x000e9; and colleagues (PNEJI1_002926 locus) [<xref rid="B18-jof-07-00849" ref-type="bibr">18</xref>] corresponds to allele <italic toggle="yes">IMPDH-2</italic>. This allele was only identified in six control patients (C3, C4, C7, C9, C12 and C15). Interestingly, allele <italic toggle="yes">IMPDH-3</italic> was only identified in the 10 SOT recipients. Allele <italic toggle="yes">IMPDH-4</italic> was only identified in three control patients (C6, C14 and C16). Allele <italic toggle="yes">IMPDH-5</italic> was only identified in nine control patients (C2, C5, C7, C8, C10, C11, C12, C13, C16). Alleles <italic toggle="yes">IMPDH-6</italic>, <italic toggle="yes">IMPDH-7</italic> and <italic toggle="yes">IMPDH-8</italic> were only identified in one patient each (respectively, C2, C10 and C13).</p><p>To sum up, allele <italic toggle="yes">IMPDH-3</italic> was only identified in SOT recipients (10/10 vs. 0/16, <italic toggle="yes">p</italic> &#x0003c; 0.0001). Only two alleles, <italic toggle="yes">IMPDH-1</italic> and <italic toggle="yes">IMPDH-3</italic> were identified in the SOT group, whereas seven alleles, <italic toggle="yes">IMPDH-1</italic>, <italic toggle="yes">IMPDH-2</italic>, <italic toggle="yes">IMPDH-4</italic>, <italic toggle="yes">IMPDH-5</italic>, <italic toggle="yes">IMPDH-6</italic>, <italic toggle="yes">IMPDH-7</italic> and <italic toggle="yes">IMPDH-8</italic>, were identified in the control group. <italic toggle="yes">IMPDH-1</italic> was the sole common allele found in both SOT and control group. Mixed infections were observed in 2 out of 10 SOT recipients and 9 out of 16 control patients (<italic toggle="yes">p</italic> = 0.11). An overall lower diversity of alleles in SOT recipients than in control patients was observed (2 alleles in 10 patients vs. 7 alleles in 16 patients).</p><p>Consensus sequences of <italic toggle="yes">P. jirovecii impdh</italic> gene in each patient were also aligned with the coding DNA sequences (CDS) of the two reference <italic toggle="yes">impdh</italic> genes (T551_00631 and PNEJI1_002926 loci) [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>,<xref rid="B18-jof-07-00849" ref-type="bibr">18</xref>]. SNP at positions 1269 and 1329 were located within introns (<xref rid="app1-jof-07-00849" ref-type="app">Figure S2</xref>). SNP at position 76, 914, 1020, 1737, 1754, 1850 and 1952 were located within exons. Deduced protein sequences were compared to the reference protein sequences (UniProt ID A0A0W4ZU90 and L0P7N3) [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>,<xref rid="B18-jof-07-00849" ref-type="bibr">18</xref>]. Four synonymous mutations and 3 missense mutations were identified. Missense mutations were observed at nucleotide positions 76, 1020 and 1737. The first mutation corresponds to a transversion from G to T (G76T) and an amino acid substitution from alanine (Ala) to serine (Ser) at codon 26 (Ala26Ser) (<xref rid="app1-jof-07-00849" ref-type="app">Figure S2</xref>; <xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>). This change characterising the allele <italic toggle="yes">IMPDH-7</italic> was found in one control patient (C10). The second mutation corresponds to a transition from G to A (G1020A) and an amino acid substitution from alanine to threonine (Thr) at codon 261 (Ala261Thr) (<xref rid="app1-jof-07-00849" ref-type="app">Figure S2</xref>; <xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>). It is noteworthy that this change characterising the allele <italic toggle="yes">IMPDH-3</italic> was exclusively found in the SOT recipients and in all of those. The third mutation, found in three control patients (C6, C14 and C16) but not in SOT recipients, corresponds to a transition from G to A (G1737A) and an amino acid substitution from glycine to serine at codon 439 (Gly439Ser) (<xref rid="app1-jof-07-00849" ref-type="app">Figure S2</xref>; <xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>). This change characterising the allele <italic toggle="yes">IMPDH-4</italic> was found in three control patients (C6, C14 and C16) and was not found in SOT recipients. </p><p><italic toggle="yes">P. jirovecii</italic> IMPDH protein sequences were aligned with available IMPDH proteins from relevant fungi, i.e., the IMPDH of other species of the <italic toggle="yes">Pneumocystis</italic> genus (<italic toggle="yes">P. carinii</italic>, <italic toggle="yes">P. murina</italic>) [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>], <italic toggle="yes">C. albicans</italic> [<xref rid="B21-jof-07-00849" ref-type="bibr">21</xref>], <italic toggle="yes">M. guilliermondii</italic> [<xref rid="B22-jof-07-00849" ref-type="bibr">22</xref>], <italic toggle="yes">S. cerevisiae</italic> [<xref rid="B23-jof-07-00849" ref-type="bibr">23</xref>], <italic toggle="yes">P. brevicompactum</italic> [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>] and <italic toggle="yes">A. nidulans</italic> [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>] (<xref rid="app1-jof-07-00849" ref-type="app">Table S2</xref>) (<xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>). The two IMPDHs of <italic toggle="yes">P. jirovecii</italic> that were retrieved from the two available proteomes (one from Ma and colleagues, the other from Ciss&#x000e9; and colleagues) are identical and can be considered as the wild type of IMPDH [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>,<xref rid="B18-jof-07-00849" ref-type="bibr">18</xref>]. Among the three aforementioned missense mutations identified in the present study, the mutations Ala26Ser and Gly439Ser are located within non-conserved regions (<xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>,<xref rid="B25-jof-07-00849" ref-type="bibr">25</xref>]. Conversely, mutation Ala261Thr is located in a strongly conserved region, Ala261 being itself a strongly conserved residue (<xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>]. Indeed, an Ala was observed at the analogous positions within the IMPDHs of <italic toggle="yes">P. jirovecii</italic> (wild type), <italic toggle="yes">P. carinii</italic> (Ala256), <italic toggle="yes">P. murina</italic> (Ala256), <italic toggle="yes">C. albicans</italic> (CaIMPDH-MPA<sup>S</sup>; Ala251), <italic toggle="yes">A. nidulans</italic> (Ala267) and the MPA-sensitive IMPDHs of <italic toggle="yes">M. guilliermondii</italic> (MgIMPDH1-MPA<sup>S</sup>; Ala251) and <italic toggle="yes">S. cerevisiae</italic> (ScIMPDH2-MPA<sup>S</sup>; Ala253) (<xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>). Conversely, a Thr was observed at the analogous position within the IMPDH of an MPA-resistant <italic toggle="yes">C. albicans</italic> strain (CaIMPDH-MPA<sup>R</sup>; Thr251) and a Ser was observed at the analogous position within the MPA-resistant IMPDHs of <italic toggle="yes">M. guilliermondii</italic> (MgIMPDH2-MPA<sup>R</sup>; Ser251), <italic toggle="yes">S. cerevisiae</italic> (ScIMPDH2-MPA<sup>R</sup>; Ser253) and <italic toggle="yes">P. brevicompactum</italic> (Ala267).</p></sec><sec sec-type="discussion" id="sec4-jof-07-00849"><title>4. Discussion</title><p>In this study, the first data on <italic toggle="yes">P. jirovecii impdh</italic> gene diversity were obtained. To the best of our knowledge, data on the diversity of the <italic toggle="yes">impdh</italic> gene in the most studied <italic toggle="yes">Pneumocystis</italic> species, specifically <italic toggle="yes">P. carinii</italic>, from rats and <italic toggle="yes">P. murina</italic>, from mice, are not available. Nonetheless, IMPDH of <italic toggle="yes">P. carinii</italic> as a potential drug target of MPA was previously evaluated by O&#x02019;Gara and colleagues [<xref rid="B16-jof-07-00849" ref-type="bibr">16</xref>]. <italic toggle="yes">P. carinii</italic>&#x02019;s sensitivity to MPA was established using a short-term culture of <italic toggle="yes">P. carinii</italic> [<xref rid="B16-jof-07-00849" ref-type="bibr">16</xref>]. This sensitivity was confirmed using an IMPDH-deficient strain of <italic toggle="yes">Escherichia coli</italic> complemented with a plasmid containing the <italic toggle="yes">P. carinii impdh</italic> gene [<xref rid="B16-jof-07-00849" ref-type="bibr">16</xref>].</p><p>Among the nine SNP identified in the overall <italic toggle="yes">P. jirovecii</italic> specimens from 26 patients, 6 were synonymous mutations, whereas 3 others, Ala26Ser, Ala261Thr and Gly439Ser, resulted in missense mutations. Since the two first mutations Ala26Ser and Gly439Ser are located within non-conserved regions, they might represent natural polymorphisms that might not affect protein function as it has been established in the human IMPDH1 (hIMPDH1) [<xref rid="B7-jof-07-00849" ref-type="bibr">7</xref>,<xref rid="B26-jof-07-00849" ref-type="bibr">26</xref>]. Nonetheless, since the mutation Gly439Ser is located in a hinge region, an effect on enzymatic activity cannot be ruled out.</p><p>The mutation Ala261Thr is located in a highly conserved region in fungal IMPDHs, Ala being itself a highly conserved residue, considering our alignments (<xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>) combined with data reported by Freedman and colleagues [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>] who aligned 20,000 fungal IMPDHs and found that the residues at analogous position 261 (the position identified in <italic toggle="yes">P. jirovecii</italic> IMPDH in the present study) were 91% Ala, 7.3% Gly, 1.2% Ser, 0.1% Thr and 0.1% Val [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>]. Interestingly, fungi displaying natural or acquired resistance to MPA or at least naturally exposed to MPA in their environment were previously described to harbour a Ser or a Thr residue at the corresponding position in the IMPDH protein sequence. For example, a substitution from Ala to Thr (Ala251Thr) has been identified in an MPA-resistant strain of <italic toggle="yes">C. albicans</italic> selected under a high concentration of MPA (10 &#x000b5;g/mL) (<xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B21-jof-07-00849" ref-type="bibr">21</xref>]. Similarly, <italic toggle="yes">P. brevicompactum</italic> IMPDH-A (PbIMPDHA-MPA<sup>R</sup>), <italic toggle="yes">S. cerevisiae</italic> IMPDH2 (ScIMPDH2-MPA<sup>R</sup>) and <italic toggle="yes">M. guillermondii</italic> IMPDH2 (MgIMPDH2-MPA<sup>R</sup>) harbour a substitution from Ala to Ser at the analogous position (Ala267Ser, Ala253Ser and Ala251Ser, respectively) [<xref rid="B22-jof-07-00849" ref-type="bibr">22</xref>,<xref rid="B23-jof-07-00849" ref-type="bibr">23</xref>,<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>] (<xref rid="jof-07-00849-f001" ref-type="fig">Figure 1</xref>), these three fungi being naturally resistant to MPA. Consequently, the Ala to Ser or Thr substitution in IMPDHs thus, stands out as a critical determinant of MPA-resistance in fungi [<xref rid="B22-jof-07-00849" ref-type="bibr">22</xref>,<xref rid="B23-jof-07-00849" ref-type="bibr">23</xref>,<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>]. Moreover, the in vitro substitution of Ala267 with Ser made the IMPDH of <italic toggle="yes">Aspergillus nidulans</italic>, a naturally MPA-sensitive fungus, resistant to MPA [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>].</p><p>Interestingly, the mutation Ala261Thr in <italic toggle="yes">P. jirovecii</italic> IMPDH was found only in the 10 SOT recipients enrolled in the study, all of them being still subject to anti-rejection treatment with MPA at the date of PCP diagnosis. Nonetheless, putative resistance of <italic toggle="yes">P. jirovecii</italic> to MPA is probably not a risk factor for PCP occurrence. Indeed, the patients developed PCP because none of them were undergoing chemoprophylaxis when <italic toggle="yes">P. jirovecii</italic> infections occurred. In fact, the post-transplantation period ranged from 8 months to 216 months, whereas the duration of recommended prophylaxis is limited to 6&#x02013;12 months after transplantation [<xref rid="B5-jof-07-00849" ref-type="bibr">5</xref>]. However, the mutation Ala261Thr among <italic toggle="yes">P. jirovecii</italic> isolates from SOT patients may represent a signature of MPA exposure and the circulation and transmission of specific <italic toggle="yes">P. jirovecii</italic> strains in susceptible patient populations. This signature of MPA exposure was previously pointed out in environmental fungal species such as <italic toggle="yes">Aspergillus glaucus, Aspergillus clavatus, Aspergillus terreus,</italic> which encode IMPDHs harbouring Ser or Thr at the analogous position [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>]. These environmental moulds have probably been confronted with MPA during their evolution since they are known to develop in natural niches shared with <italic toggle="yes">Penicillium</italic> species that naturally produce MPA [<xref rid="B24-jof-07-00849" ref-type="bibr">24</xref>].</p><p>Consequently, MPA may have favoured the emergence of specific strains of <italic toggle="yes">P. jirovecii</italic> revealed by this specific mutation in SOT recipients. It is noteworthy that SOT recipients T3 and T9 harboured allele <italic toggle="yes">IMPDH-3</italic> (characterised by the G1020A mutation resulting in Ala261Thr) in combination with allele <italic toggle="yes">IMPDH-1</italic>, whereas the remaining eight SOT recipients harboured <italic toggle="yes">IMPDH-3</italic> solely. These mixed infections may be explained by an in-progress process of selection of <italic toggle="yes">P. jirovecii</italic> organisms under MPA pressure, wild <italic toggle="yes">P. jirovecii</italic> strains being not entirely replaced by a predominant mutant <italic toggle="yes">P. jirovecii</italic> strain. While MPA was initially considered to protect against <italic toggle="yes">P. jirovecii</italic> in the 1990s [<xref rid="B8-jof-07-00849" ref-type="bibr">8</xref>], an increase in PCP cases in SOT recipients has been reported, particularly in RTR, in a context of nosocomial infection over the past 15 years [<xref rid="B6-jof-07-00849" ref-type="bibr">6</xref>,<xref rid="B27-jof-07-00849" ref-type="bibr">27</xref>]. At present, MPA is identified as one of risk factors for PCP [<xref rid="B28-jof-07-00849" ref-type="bibr">28</xref>]. This paradigm shift could be explained in part by MPA pressure on <italic toggle="yes">P. jirovecii</italic> populations, selection of specific strains characterised by potentially lower sensitivity to MPA and acquisition/transmission of these specific strains among susceptible SOT recipients.</p><p>The phenomenon of <italic toggle="yes">P. jirovecii</italic> selection under drug pressure has already been reported with the description of specific genotypes/phenotypes of dihydropteroate synthase (DHPS) in patients treated with sulfonamides that target the DHPS [<xref rid="B14-jof-07-00849" ref-type="bibr">14</xref>,<xref rid="B29-jof-07-00849" ref-type="bibr">29</xref>,<xref rid="B30-jof-07-00849" ref-type="bibr">30</xref>]. Prior exposure to these drugs was identified as the main predictor of <italic toggle="yes">P. jirovecii</italic> DHPS mutants [<xref rid="B14-jof-07-00849" ref-type="bibr">14</xref>,<xref rid="B29-jof-07-00849" ref-type="bibr">29</xref>,<xref rid="B30-jof-07-00849" ref-type="bibr">30</xref>]. The patients&#x02019; city of residence, whether or not they had prior exposure to sulfonamides, has been identified as another predictor of <italic toggle="yes">P. jirovecii</italic> DHPS mutants [<xref rid="B14-jof-07-00849" ref-type="bibr">14</xref>,<xref rid="B29-jof-07-00849" ref-type="bibr">29</xref>]. This observation was explained by possible <italic toggle="yes">P. jirovecii</italic> transmission from infected, treated patients to susceptible, untreated patients. Similarly, we recently described a <italic toggle="yes">P. jirovecii</italic> mutant of the gene of cytochrome b (CYB), which is the target of atovaquone [<xref rid="B11-jof-07-00849" ref-type="bibr">11</xref>]. This mutant was spread in HTR who were effectively subject to PCP prophylaxis by atovaquone, but also in HTR without prior exposure to atovaquone, in a context of PCP outbreak [<xref rid="B11-jof-07-00849" ref-type="bibr">11</xref>]. For these reasons, analysis of DHPS locus and CYB genes serves as a marker of <italic toggle="yes">P. jirovecii</italic> circulation within human communities.</p><p>The presence of allele <italic toggle="yes">IMPDH-3</italic> (characterised by the G1020A mutation resulting in Ala261Thr) and the low diversity of the <italic toggle="yes">P. jirovecii impdh</italic> gene in SOT recipients suggest a common identical source of the fungus in this patient group. Conversely, the high diversity of <italic toggle="yes">impdh</italic> gene, as well as the absence of the <italic toggle="yes">IMPDH-3</italic> allele suggest several different sources of <italic toggle="yes">P. jirovecii</italic> in the control group. This diversity resulted in the identification of nine SNPs and eight alleles.</p><p>Considering the potential of <italic toggle="yes">impdh</italic> gene analysis in contributing to a method of <italic toggle="yes">P. jirovecii</italic> genotyping, we evaluated the Hunter index at 0.6952 (&#x0003c;0.95) [<xref rid="B31-jof-07-00849" ref-type="bibr">31</xref>]. This value is insufficient to distinguish <italic toggle="yes">P. jirovecii</italic> isolates in a genotyping approach based on this sole locus. Nonetheless, <italic toggle="yes">impdh</italic> gene analysis could be added to the highly discriminative multilocus sequence typing (MLST) method combining mtLSUrRNA, CYB and superoxide dismutase gene analysis, that we have used to investigate <italic toggle="yes">Pneumocystis</italic> case clusters in hospital [<xref rid="B32-jof-07-00849" ref-type="bibr">32</xref>]. <italic toggle="yes">Impdh</italic> gene analysis could provide an additional marker of <italic toggle="yes">P. jirovecii</italic> circulation among SOT recipients who are specifically at risk for PCP occurrence in a context of nosocomial acquisition of <italic toggle="yes">P. jirovecii</italic> and PCP outbreaks. MLST analysis including <italic toggle="yes">impdh</italic> gene may strengthen the concept of acquisition and transmission of specific <italic toggle="yes">P. jirovecii</italic> strains in SOT recipients, which has previously been discussed [<xref rid="B6-jof-07-00849" ref-type="bibr">6</xref>,<xref rid="B33-jof-07-00849" ref-type="bibr">33</xref>,<xref rid="B34-jof-07-00849" ref-type="bibr">34</xref>].</p><p>To sum up, we pointed out a missense mutation Ala261Thr in SOT recipients treated with MPA, whereas this change was not found in a control group without prior exposure to MPA. This mutation may represent the signature of MPA exposure and the selection of specific <italic toggle="yes">P. jirovecii</italic> strains under selection pressure that circulate in the SOT recipient population. A multicentre study, combining the enrolment of patients from diverse geographical regions and the genotyping of <italic toggle="yes">P. jirovecii</italic> specimens based on the aforementioned MLST approach is now warranted.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-jof-07-00849"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/article/10.3390/jof7100849/s1">https://www.mdpi.com/article/10.3390/jof7100849/s1</uri>, Figure S1: Description of PCR products obtained using the six primer pairs designed for Pneumocystis jirovecii impdh gene amplification, Figure S2: Alignment of impdh CDS and genomic sequences of the two P.jirovecii genome assemblies, Figure S3: Diversity of the impdh gene of Pneumocystis jirovecii based on the analysis of 26 specimens, Table S1: Nucleotide sequences of primers used for amplification of Pneumocystis jirovecii impdh gene, Table S2: List of the IMPDH protein sequences from <italic toggle="yes">Pneumocystis</italic> species and other fungi that were aligned with the IMPDH sequences obtained in the present study.</p><supplementary-material id="jof-07-00849-s001" position="float" content-type="local-data"><media xlink:href="jof-07-00849-s001.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, G.N., N.P., J.-P.B. and S.L.G.; Methodology, G.N. and S.L.G.; Validation, C.V.H. and S.L.G.; Formal Analysis, C.V.H. and S.L.G.; Investigation, C.V.H., N.L.N. and S.L.G.; Resources, D.Q., M.-C.M. and Y.L.M.; Writing&#x02014;Original Draft Preparation, C.V.H., S.L.G. and G.N.; Writing&#x02014;Review and Editing, all authors; Visualization, C.V.H. and S.L.G.; Supervision, S.L.G. and G.N. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes><title>Institutional Review Board Statement</title><p>Ethical review and approval were waived for this study, in accordance with the French public health law (CSP Art L1121e1.1), because this study was non-interventional, focused on <italic toggle="yes">P. jirovecii</italic> specimens and used samplings and data obtained from the patients&#x02019; standard routine care.</p></notes><notes><title>Informed Consent Statement</title><p>Patients&#x02019; consent were not required for this study, in accordance with the French public health law, because this protocol only used samplings and data obtained from the patients&#x02019; standard routine care.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The nucleotide sequences of the <italic toggle="yes">impdh</italic> gene obtained in the present study have been deposited in GenBank under accession numbers from MZ272376 to MZ272401.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>All authors report no conflict of interest relevant to this article. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></notes><ref-list><title>References</title><ref id="B1-jof-07-00849"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cazein</surname><given-names>F.</given-names></name>
<name><surname>Lot</surname><given-names>F.</given-names></name>
<name><surname>Pillonel</surname><given-names>J.</given-names></name>
<name><surname>Le Strat</surname><given-names>Y.</given-names></name>
<name><surname>Sommen</surname><given-names>C.</given-names></name>
<name><surname>Pinget</surname><given-names>R.</given-names></name>
<name><surname>Le Vu</surname><given-names>S.</given-names></name>
<name><surname>Brunet</surname><given-names>S.</given-names></name>
<name><surname>Thierry</surname><given-names>D.</given-names></name>
<name><surname>Brand</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>D&#x000e9;couvertes de s&#x000e9;ropositivit&#x000e9; VIH et de SIDA, France, 2003&#x02013;2013</article-title><source>Bull. Epidemiol. Hebd</source><year>2015</year><volume>9&#x02013;10</volume><fpage>152</fpage><lpage>161</lpage></element-citation></ref><ref id="B2-jof-07-00849"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bitar</surname><given-names>D.</given-names></name>
<name><surname>Lortholary</surname><given-names>O.</given-names></name>
<name><surname>Le Strat</surname><given-names>Y.</given-names></name>
<name><surname>Nicolau</surname><given-names>J.</given-names></name>
<name><surname>Coignard</surname><given-names>B.</given-names></name>
<name><surname>Tattevin</surname><given-names>P.</given-names></name>
<name><surname>Che</surname><given-names>D.</given-names></name>
<name><surname>Dromer</surname><given-names>F.</given-names></name>
</person-group><article-title>Population-Based Analysis of Invasive Fungal Infections, France, 2001&#x02013;2010</article-title><source>Emerg. Infect. Dis.</source><year>2014</year><volume>20</volume><fpage>1163</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.3201/eid2007.140087</pub-id></element-citation></ref><ref id="B3-jof-07-00849"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Roux</surname><given-names>A.</given-names></name>
<name><surname>Canet</surname><given-names>E.</given-names></name>
<name><surname>Valade</surname><given-names>S.</given-names></name>
<name><surname>Gangneux-Robert</surname><given-names>F.</given-names></name>
<name><surname>Hamane</surname><given-names>S.</given-names></name>
<name><surname>Lafabrie</surname><given-names>A.</given-names></name>
<name><surname>Maubon</surname><given-names>D.</given-names></name>
<name><surname>Debourgogne</surname><given-names>A.</given-names></name>
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Dalle</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Pneumocystis jirovecii</italic> Pneumonia in Patients with or without AIDS, France</article-title><source>Emerg. Infect. Dis.</source><year>2014</year><volume>20</volume><fpage>1490</fpage><lpage>1497</lpage><pub-id pub-id-type="doi">10.3201/eid2009.131668</pub-id><pub-id pub-id-type="pmid">25148074</pub-id></element-citation></ref><ref id="B4-jof-07-00849"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gordon</surname><given-names>S.M.</given-names></name>
<name><surname>LaRosa</surname><given-names>S.P.</given-names></name>
<name><surname>Kalmadi</surname><given-names>S.</given-names></name>
<name><surname>Arroliga</surname><given-names>A.C.</given-names></name>
<name><surname>Avery</surname><given-names>R.K.</given-names></name>
<name><surname>LaRosa</surname><given-names>T.</given-names></name>
<name><surname>Longworth</surname><given-names>D.L.</given-names></name>
</person-group><article-title>Should prophylaxis for <italic toggle="yes">Pneumocystis carinii</italic> pneumonia in solid organ transplant recipients ever be discontinued?</article-title><source>Clin. Infect. Dis.</source><year>1999</year><volume>28</volume><fpage>240</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1086/515126</pub-id><pub-id pub-id-type="pmid">10064238</pub-id></element-citation></ref><ref id="B5-jof-07-00849"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Green</surname><given-names>H.</given-names></name>
<name><surname>Paul</surname><given-names>M.</given-names></name>
<name><surname>Vidal</surname><given-names>L.</given-names></name>
<name><surname>Leibovici</surname><given-names>L.</given-names></name>
</person-group><article-title>Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients</article-title><source>Cochrane Database Syst. Rev.</source><year>2007</year><volume>2014</volume><fpage>CD005590</fpage></element-citation></ref><ref id="B6-jof-07-00849"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Toubas</surname><given-names>D.</given-names></name>
<name><surname>Totet</surname><given-names>A.</given-names></name>
<name><surname>Dalle</surname><given-names>F.</given-names></name>
<name><surname>Bacar</surname><given-names>A.A.</given-names></name>
<name><surname>Le Meur</surname><given-names>Y.</given-names></name>
<name><surname>Nevez</surname><given-names>G.</given-names></name>
<collab>Anofel Association</collab>
</person-group><article-title>Pneumocystis Infection Outbreaks in Organ Transplantation Units in France: A Nation-Wide Survey</article-title><source>Clin. Infect. Dis.</source><year>2020</year><volume>70</volume><fpage>2216</fpage><lpage>2220</lpage><pub-id pub-id-type="doi">10.1093/cid/ciz901</pub-id><?supplied-pmid 31633150?><pub-id pub-id-type="pmid">31633150</pub-id></element-citation></ref><ref id="B7-jof-07-00849"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hedstrom</surname><given-names>L.</given-names></name>
</person-group><article-title>IMP Dehydrogenase: Structure, Mechanism, and Inhibition</article-title><source>Chem. Rev.</source><year>2009</year><volume>109</volume><fpage>2903</fpage><lpage>2928</lpage><pub-id pub-id-type="doi">10.1021/cr900021w</pub-id><?supplied-pmid 19480389?><pub-id pub-id-type="pmid">19480389</pub-id></element-citation></ref><ref id="B8-jof-07-00849"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Husain</surname><given-names>S.</given-names></name>
<name><surname>Singh</surname><given-names>N.</given-names></name>
</person-group><article-title>The impact of novel immunosuppressive agents on infections in organ transplant recipients and the in-teractions of these agents with antimicrobials</article-title><source>Clin. Infect. Dis.</source><year>2002</year><volume>35</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1086/340867</pub-id><pub-id pub-id-type="pmid">12060875</pub-id></element-citation></ref><ref id="B9-jof-07-00849"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oz</surname><given-names>H.S.</given-names></name>
<name><surname>Hughes</surname><given-names>W.T.</given-names></name>
</person-group><article-title>Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone</article-title><source>J. Infect. Dis.</source><year>1997</year><volume>175</volume><fpage>901</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1086/513988</pub-id><pub-id pub-id-type="pmid">9086147</pub-id></element-citation></ref><ref id="B10-jof-07-00849"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Damiani</surname><given-names>C.</given-names></name>
<name><surname>Rouille</surname><given-names>A.</given-names></name>
<name><surname>Grall</surname><given-names>A.</given-names></name>
<name><surname>Tr&#x000e9;guer</surname><given-names>L.</given-names></name>
<name><surname>Virmaux</surname><given-names>M.</given-names></name>
<name><surname>Moalic</surname><given-names>E.</given-names></name>
<name><surname>Quinio</surname><given-names>D.</given-names></name>
<name><surname>Moal</surname><given-names>M.-C.</given-names></name>
<name><surname>Berthou</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>A cluster of Pneumocystis infections among renal transplant recipients: Molecular evidence of colonized patients as potential infectious sources of <italic toggle="yes">Pneumocystis jirovecii</italic></article-title><source>Clin. Infect. Dis.</source><year>2012</year><volume>54</volume><fpage>e62</fpage><lpage>e71</lpage><pub-id pub-id-type="doi">10.1093/cid/cir996</pub-id><pub-id pub-id-type="pmid">22337822</pub-id></element-citation></ref><ref id="B11-jof-07-00849"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argy</surname><given-names>N.</given-names></name>
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Copp&#x000e9;e</surname><given-names>R.</given-names></name>
<name><surname>Song</surname><given-names>Z.</given-names></name>
<name><surname>Vindrios</surname><given-names>W.</given-names></name>
<name><surname>Massias</surname><given-names>L.</given-names></name>
<name><surname>Kao</surname><given-names>W.-C.</given-names></name>
<name><surname>Hunte</surname><given-names>C.</given-names></name>
<name><surname>Yazdanpanah</surname><given-names>Y.</given-names></name>
<name><surname>Lucet</surname><given-names>J.-C.</given-names></name>
<etal/>
</person-group><article-title>Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients</article-title><source>Clin. Infect. Dis.</source><year>2018</year><volume>67</volume><fpage>913</fpage><lpage>919</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy154</pub-id><pub-id pub-id-type="pmid">29514207</pub-id></element-citation></ref><ref id="B12-jof-07-00849"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nevez</surname><given-names>G.</given-names></name>
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Noel</surname><given-names>N.</given-names></name>
<name><surname>Wynckel</surname><given-names>A.</given-names></name>
<name><surname>Huguenin</surname><given-names>A.</given-names></name>
<name><surname>Le Govic</surname><given-names>Y.</given-names></name>
<name><surname>Pougnet</surname><given-names>L.</given-names></name>
<name><surname>Virmaux</surname><given-names>M.</given-names></name>
<name><surname>Toubas</surname><given-names>D.</given-names></name>
<name><surname>Bajolet</surname><given-names>O.</given-names></name>
</person-group><article-title>Investigation of nosocomial pneumocystis infections: Usefulness of longitudinal screening of epidemic and post-epidemic pneumocystis genotypes</article-title><source>J. Hosp. Infect.</source><year>2018</year><volume>99</volume><fpage>332</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2017.09.015</pub-id><pub-id pub-id-type="pmid">28943270</pub-id></element-citation></ref><ref id="B13-jof-07-00849"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Staib</surname><given-names>P.</given-names></name>
<name><surname>Michel</surname><given-names>S.</given-names></name>
<name><surname>K&#x000f6;hler</surname><given-names>G.</given-names></name>
<name><surname>Morschh&#x000e4;user</surname><given-names>J.</given-names></name>
</person-group><article-title>A molecular genetic system for the pathogenic yeast <italic toggle="yes">Candida dubliniensis</italic></article-title><source>Gene</source><year>2000</year><volume>242</volume><fpage>303</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/S0378-1119(99)00512-0</pub-id></element-citation></ref><ref id="B14-jof-07-00849"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matos</surname><given-names>O.</given-names></name>
<name><surname>Esteves</surname><given-names>F.</given-names></name>
</person-group><article-title>Epidemiology and clinical relevance of <italic toggle="yes">Pneumocystis jirovecii</italic> Frenkel, 1976 dihydropteroate synthase gene mutations</article-title><source>Parasite</source><year>2010</year><volume>17</volume><fpage>219</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1051/parasite/2010173219</pub-id><pub-id pub-id-type="pmid">21073145</pub-id></element-citation></ref><ref id="B15-jof-07-00849"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Robert-Gangneux</surname><given-names>F.</given-names></name>
<name><surname>Pepino</surname><given-names>Y.</given-names></name>
<name><surname>Belaz</surname><given-names>S.</given-names></name>
<name><surname>Damiani</surname><given-names>C.</given-names></name>
<name><surname>Gu&#x000e9;guen</surname><given-names>P.</given-names></name>
<name><surname>Pitous</surname><given-names>M.</given-names></name>
<name><surname>Virmaux</surname><given-names>M.</given-names></name>
<name><surname>Lissilour</surname><given-names>E.</given-names></name>
<name><surname>Pougnet</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>A misleading false-negative result of Pneumocystis real-time PCR assay due to a rare punctual mutation: A French multicenter study</article-title><source>Med. Mycol.</source><year>2017</year><volume>55</volume><fpage>180</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1093/mmy/myw051</pub-id><pub-id pub-id-type="pmid">27489302</pub-id></element-citation></ref><ref id="B16-jof-07-00849"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>O&#x02019;Gara</surname><given-names>M.J.</given-names></name>
<name><surname>Lee</surname><given-names>C.H.</given-names></name>
<name><surname>Weinberg</surname><given-names>G.A.</given-names></name>
<name><surname>Nott</surname><given-names>J.M.</given-names></name>
<name><surname>Queener</surname><given-names>S.F.</given-names></name>
</person-group><article-title>IMP dehydrogenase from Pneumocystis carinii as a potential drug target</article-title><source>Antimicrob. Agents Chemother.</source><year>1997</year><volume>41</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1128/AAC.41.1.40</pub-id><pub-id pub-id-type="pmid">8980752</pub-id></element-citation></ref><ref id="B17-jof-07-00849"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>Z.</given-names></name>
<name><surname>Huang</surname><given-names>D.W.</given-names></name>
<name><surname>Kutty</surname><given-names>G.</given-names></name>
<name><surname>Ishihara</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Abouelleil</surname><given-names>A.</given-names></name>
<name><surname>Bishop</surname><given-names>L.</given-names></name>
<name><surname>Davey</surname><given-names>E.</given-names></name>
<name><surname>Deng</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts</article-title><source>Nat. Commun.</source><year>2016</year><volume>7</volume><fpage>10740</fpage><pub-id pub-id-type="doi">10.1038/ncomms10740</pub-id><?supplied-pmid 26899007?><pub-id pub-id-type="pmid">26899007</pub-id></element-citation></ref><ref id="B18-jof-07-00849"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ciss&#x000e9;</surname><given-names>O.H.</given-names></name>
<name><surname>Pagni</surname><given-names>M.</given-names></name>
<name><surname>Hauser</surname><given-names>P.M.</given-names></name>
</person-group><article-title>De Novo Assembly of the <italic toggle="yes">Pneumocystis jirovecii</italic> Genome from a Single Bronchoalveolar Lavage Fluid Specimen from a Patient</article-title><source>mBio</source><year>2013</year><volume>4</volume><fpage>e00428-12</fpage><pub-id pub-id-type="doi">10.1128/mBio.00428-12</pub-id><?supplied-pmid 23269827?><pub-id pub-id-type="pmid">23269827</pub-id></element-citation></ref><ref id="B19-jof-07-00849"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Crooks</surname><given-names>G.E.</given-names></name>
<name><surname>Hon</surname><given-names>G.</given-names></name>
<name><surname>Chandonia</surname><given-names>J.-M.</given-names></name>
<name><surname>Brenner</surname><given-names>S.E.</given-names></name>
</person-group><article-title>WebLogo: A Sequence Logo Generator</article-title><source>Genome Res.</source><year>2004</year><volume>14</volume><fpage>1188</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1101/gr.849004</pub-id><?supplied-pmid 15173120?><pub-id pub-id-type="pmid">15173120</pub-id></element-citation></ref><ref id="B20-jof-07-00849"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Di Tommaso</surname><given-names>P.</given-names></name>
<name><surname>Moretti</surname><given-names>S.</given-names></name>
<name><surname>Xenarios</surname><given-names>I.</given-names></name>
<name><surname>Orobitg</surname><given-names>M.</given-names></name>
<name><surname>Montanyola</surname><given-names>A.</given-names></name>
<name><surname>Chang</surname><given-names>J.-M.</given-names></name>
<name><surname>Taly</surname><given-names>J.-F.</given-names></name>
<name><surname>Notredame</surname><given-names>C.</given-names></name>
</person-group><article-title>T-Coffee: A web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension</article-title><source>Nucleic Acids Res.</source><year>2011</year><volume>39</volume><fpage>W13</fpage><lpage>W17</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr245</pub-id><?supplied-pmid 21558174?><pub-id pub-id-type="pmid">21558174</pub-id></element-citation></ref><ref id="B21-jof-07-00849"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>K&#x000f6;hler</surname><given-names>G.A.</given-names></name>
<name><surname>Gong</surname><given-names>X.</given-names></name>
<name><surname>Bentink</surname><given-names>S.</given-names></name>
<name><surname>Theiss</surname><given-names>S.</given-names></name>
<name><surname>Pagani</surname><given-names>G.M.</given-names></name>
<name><surname>Agabian</surname><given-names>N.</given-names></name>
<name><surname>Hedstrom</surname><given-names>L.</given-names></name>
</person-group><article-title>The functional basis of mycophenolic acid resistance in <italic toggle="yes">Candida albicans</italic> IMP dehydro-genase</article-title><source>J. Biol. Chem.</source><year>2005</year><volume>280</volume><fpage>11295</fpage><lpage>11302</lpage><pub-id pub-id-type="doi">10.1074/jbc.M409847200</pub-id><pub-id pub-id-type="pmid">15665003</pub-id></element-citation></ref><ref id="B22-jof-07-00849"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Defosse</surname><given-names>T.A.</given-names></name>
<name><surname>M&#x000e9;lin</surname><given-names>C.</given-names></name>
<name><surname>Clastre</surname><given-names>M.</given-names></name>
<name><surname>Besseau</surname><given-names>S.</given-names></name>
<name><surname>Lanoue</surname><given-names>A.</given-names></name>
<name><surname>Gl&#x000e9;varec</surname><given-names>G.</given-names></name>
<name><surname>Oudin</surname><given-names>A.</given-names></name>
<name><surname>Dug&#x000e9; de Bernonville</surname><given-names>T.</given-names></name>
<name><surname>Vandeputte</surname><given-names>P.</given-names></name>
<name><surname>Linder</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>An additional <italic toggle="yes">Meyerozyma guilliermondii</italic> IMH3 gene confers mycophenolic acid re-sistance in fungal CTG clade species</article-title><source>FEMS Yeast Res.</source><year>2016</year><volume>16</volume><fpage>fow078</fpage><pub-id pub-id-type="doi">10.1093/femsyr/fow078</pub-id><pub-id pub-id-type="pmid">27620459</pub-id></element-citation></ref><ref id="B23-jof-07-00849"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jenks</surname><given-names>M.H.</given-names></name>
<name><surname>Reines</surname><given-names>D.</given-names></name>
</person-group><article-title>Dissection of the molecular basis of mycophenolate resistance in <italic toggle="yes">Saccharomyces cerevisiae</italic></article-title><source>Yeast</source><year>2005</year><volume>22</volume><fpage>1181</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1002/yea.1300</pub-id><pub-id pub-id-type="pmid">16278936</pub-id></element-citation></ref><ref id="B24-jof-07-00849"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Freedman</surname><given-names>R.</given-names></name>
<name><surname>Yu</surname><given-names>R.</given-names></name>
<name><surname>Sarkis</surname><given-names>A.W.</given-names></name>
<name><surname>Hedstrom</surname><given-names>L.</given-names></name>
</person-group><article-title>A structural determinant of mycophenolic acid resistance in eukaryotic inosine 5&#x02032;-monophosphate dehydrogenases</article-title><source>Protein Sci.</source><year>2019</year><volume>29</volume><fpage>686</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1002/pro.3766</pub-id><pub-id pub-id-type="pmid">31675145</pub-id></element-citation></ref><ref id="B25-jof-07-00849"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hansen</surname><given-names>B.G.</given-names></name>
<name><surname>Genee</surname><given-names>H.J.</given-names></name>
<name><surname>Kaas</surname><given-names>C.S.</given-names></name>
<name><surname>Nielsen</surname><given-names>J.B.</given-names></name>
<name><surname>Regueira</surname><given-names>T.B.</given-names></name>
<name><surname>Mortensen</surname><given-names>U.H.</given-names></name>
<name><surname>Frisvad</surname><given-names>J.C.</given-names></name>
<name><surname>Patil</surname><given-names>K.R.</given-names></name>
</person-group><article-title>A new class of IMP dehydrogenase with a role in self-resistance of mycophenolic acid producing fungi</article-title><source>BMC Microbiol.</source><year>2011</year><volume>11</volume><elocation-id>202</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-11-202</pub-id><pub-id pub-id-type="pmid">21923907</pub-id></element-citation></ref><ref id="B26-jof-07-00849"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gensburger</surname><given-names>O.</given-names></name>
<name><surname>Van Schaik</surname><given-names>R.H.</given-names></name>
<name><surname>Picard</surname><given-names>N.</given-names></name>
<name><surname>Le Meur</surname><given-names>Y.</given-names></name>
<name><surname>Rousseau</surname><given-names>A.</given-names></name>
<name><surname>Woillard</surname><given-names>J.-B.</given-names></name>
<name><surname>Van Gelder</surname><given-names>T.</given-names></name>
<name><surname>Marquet</surname><given-names>P.</given-names></name>
</person-group><article-title>Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil</article-title><source>Pharm. Genom.</source><year>2010</year><volume>20</volume><fpage>537</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1097/FPC.0b013e32833d8cf5</pub-id></element-citation></ref><ref id="B27-jof-07-00849"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Delli&#x000e8;re</surname><given-names>S.</given-names></name>
<name><surname>Gits-Muselli</surname><given-names>M.</given-names></name>
<name><surname>Bretagne</surname><given-names>S.</given-names></name>
<name><surname>Alanio</surname><given-names>A.</given-names></name>
</person-group><article-title>Outbreak-Causing Fungi: <italic toggle="yes">Pneumocystis jirovecii</italic></article-title><source>Mycopathologia</source><year>2020</year><volume>185</volume><fpage>783</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1007/s11046-019-00408-w</pub-id><pub-id pub-id-type="pmid">31782069</pub-id></element-citation></ref><ref id="B28-jof-07-00849"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Neff</surname><given-names>R.T.</given-names></name>
<name><surname>Jindal</surname><given-names>R.M.</given-names></name>
<name><surname>Yoo</surname><given-names>D.Y.</given-names></name>
<name><surname>Hurst</surname><given-names>F.P.</given-names></name>
<name><surname>Agodoa</surname><given-names>L.Y.</given-names></name>
<name><surname>Abbott</surname><given-names>K.C.</given-names></name>
</person-group><article-title>Analysis of USRDS: Incidence and Risk Factors for Pneumocystis jiroveci Pneumonia</article-title><source>Transplantation</source><year>2009</year><volume>88</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1097/TP.0b013e3181aad256</pub-id><?supplied-pmid 19584693?><pub-id pub-id-type="pmid">19584693</pub-id></element-citation></ref><ref id="B29-jof-07-00849"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hauser</surname><given-names>P.M.</given-names></name>
<name><surname>Nahimana</surname><given-names>A.</given-names></name>
<name><surname>Taffe</surname><given-names>P.</given-names></name>
<name><surname>Weber</surname><given-names>R.</given-names></name>
<name><surname>Francioli</surname><given-names>P.</given-names></name>
<name><surname>Bille</surname><given-names>J.</given-names></name>
<name><surname>Rabodonirina</surname><given-names>M.</given-names></name>
</person-group><article-title>Interhuman transmission as a potential key parameter for geographical variation in the prevalence of <italic toggle="yes">Pneumocystis jirovecii</italic> dihydropteroate synthase mutations</article-title><source>Clin. Infect. Dis.</source><year>2010</year><volume>51</volume><fpage>e28</fpage><lpage>e33</lpage><pub-id pub-id-type="doi">10.1086/655145</pub-id><?supplied-pmid 20604718?><pub-id pub-id-type="pmid">20604718</pub-id></element-citation></ref><ref id="B30-jof-07-00849"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nahimana</surname><given-names>A.</given-names></name>
<name><surname>Rabodonirina</surname><given-names>M.</given-names></name>
<name><surname>Helweg-Larsen</surname><given-names>J.</given-names></name>
<name><surname>Meneau</surname><given-names>I.</given-names></name>
<name><surname>Francioli</surname><given-names>P.</given-names></name>
<name><surname>Bille</surname><given-names>J.</given-names></name>
<name><surname>Hauser</surname><given-names>P.M.</given-names></name>
</person-group><article-title>Sulfa resistance and dihydropteroate synthase mutants in recurrent <italic toggle="yes">Pneumocystis carinii</italic> pneumonia</article-title><source>Emerg. Infect. Dis.</source><year>2003</year><volume>9</volume><fpage>864</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.3201/eid0907.020753</pub-id><?supplied-pmid 12890331?><pub-id pub-id-type="pmid">12890330</pub-id></element-citation></ref><ref id="B31-jof-07-00849"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hunter</surname><given-names>P.R.</given-names></name>
</person-group><article-title>Reproducibility and indices of discriminatory power of microbial typing methods</article-title><source>J. Clin. Microbiol.</source><year>1990</year><volume>28</volume><fpage>1903</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1128/jcm.28.9.1903-1905.1990</pub-id><?supplied-pmid 2229371?><pub-id pub-id-type="pmid">2229371</pub-id></element-citation></ref><ref id="B32-jof-07-00849"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vindrios</surname><given-names>W.</given-names></name>
<name><surname>Argy</surname><given-names>N.</given-names></name>
<name><surname>Le Gal</surname><given-names>S.</given-names></name>
<name><surname>Lescure</surname><given-names>F.-X.</given-names></name>
<name><surname>Massias</surname><given-names>L.</given-names></name>
<name><surname>Le</surname><given-names>M.P.</given-names></name>
<name><surname>Wolff</surname><given-names>M.</given-names></name>
<name><surname>Yazdanpanah</surname><given-names>Y.</given-names></name>
<name><surname>Nevez</surname><given-names>G.</given-names></name>
<name><surname>Houze</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Outbreak of <italic toggle="yes">Pneumocystis jirovecii</italic> Infection among Heart Transplant Recipients: Mo-lecular Investigation and Management of an Inter-human Transmission</article-title><source>Clin. Infect. Dis.</source><year>2017</year><volume>65</volume><fpage>1120</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1093/cid/cix495</pub-id><?supplied-pmid 28549105?><pub-id pub-id-type="pmid">28549105</pub-id></element-citation></ref><ref id="B33-jof-07-00849"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alanio</surname><given-names>A.</given-names></name>
<name><surname>Gits-Muselli</surname><given-names>M.</given-names></name>
<name><surname>Guigue</surname><given-names>N.</given-names></name>
<name><surname>Desnos-Ollivier</surname><given-names>M.</given-names></name>
<name><surname>Calderon</surname><given-names>E.J.</given-names></name>
<name><surname>Di Cave</surname><given-names>D.</given-names></name>
<name><surname>Dupont</surname><given-names>D.</given-names></name>
<name><surname>Hamprecht</surname><given-names>A.</given-names></name>
<name><surname>Hauser</surname><given-names>P.M.</given-names></name>
<name><surname>Helweg-Larsen</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Diversity of <italic toggle="yes">Pneumocystis jirovecii</italic> Across Europe: A Multicentre Observational Study</article-title><source>EBioMedicine</source><year>2017</year><volume>22</volume><fpage>155</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2017.06.027</pub-id><?supplied-pmid 28705464?><pub-id pub-id-type="pmid">28705464</pub-id></element-citation></ref><ref id="B34-jof-07-00849"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sassi</surname><given-names>M.</given-names></name>
<name><surname>Ripamonti</surname><given-names>C.</given-names></name>
<name><surname>Mueller</surname><given-names>N.J.</given-names></name>
<name><surname>Yazaki</surname><given-names>H.</given-names></name>
<name><surname>Kutty</surname><given-names>G.</given-names></name>
<name><surname>Ma</surname><given-names>L.</given-names></name>
<name><surname>Huber</surname><given-names>C.</given-names></name>
<name><surname>Gogineni</surname><given-names>E.</given-names></name>
<name><surname>Oka</surname><given-names>S.</given-names></name>
<name><surname>Goto</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Outbreaks of Pneumocystis Pneumonia in 2 Renal Transplant Centers Linked to a Single Strain of Pneumocystis: Implications for Transmission and Virulence</article-title><source>Clin. Infect. Dis.</source><year>2012</year><volume>54</volume><fpage>1437</fpage><lpage>1444</lpage><pub-id pub-id-type="doi">10.1093/cid/cis217</pub-id><?supplied-pmid 22431811?><pub-id pub-id-type="pmid">22431811</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jof-07-00849-f001"><label>Figure 1</label><caption><p>Sequence alignment of IMPDH proteins of <italic toggle="yes">Pneumocystis jirovecii, Pneumocystis carinii, Pneumocystis murina, Meyerozyma guilliermondii, Saccharomyces cerevisiae, Candida albicans, Penicillium brevicompactum</italic> and <italic toggle="yes">Aspergillus nidulans</italic>. Identical, strongly and weakly conserved residues are indicated by asterisks, double points and single points, respectively. Dashes indicate gaps. Polymorphic residues of <italic toggle="yes">P. jirovecii</italic> IMPDH and the analogous residues in other fungi are indicated in bold. <italic toggle="yes">PjIMPDH-A261T</italic>: IMPDH sequence of <italic toggle="yes">P. jirovecii</italic> with a missense mutation Ala261Thr identified in the present study; <italic toggle="yes">PjIMPDH-A26S</italic>: IMPDH sequence of <italic toggle="yes">P. jirovecii</italic> with a missense mutation Ala26Ser identified in the present study; <italic toggle="yes">PjIMPDH-G439S</italic>: IMPDH sequence of <italic toggle="yes">P. jirovecii</italic> with a missense mutation Gly439Ser identified in the present study; PjIMPDH-Ma: IMPDH sequence of <italic toggle="yes">P. jirovecii</italic> retrieved from Ma and colleagues&#x02019; proteome [<xref rid="B17-jof-07-00849" ref-type="bibr">17</xref>]; <italic toggle="yes">PjIMPDH</italic>-Ciss&#x000e9;: IMPDH sequence of <italic toggle="yes">P. jirovecii</italic> retrieved from Ciss&#x000e9; and colleagues&#x02019; proteome [<xref rid="B18-jof-07-00849" ref-type="bibr">18</xref>]; PcIMPDH: IMPDH sequence of <italic toggle="yes">Pneumocystis carinii</italic>; PmIMPDH: IMPDH sequence of <italic toggle="yes">Pneumocystis murina</italic>; MgIMPDH1-MPA<sup>S</sup>: MPA-sensitive IMPDH1 of <italic toggle="yes">Meyerozyma guilliermondii</italic>; MgIMPDH2-MPA<sup>R</sup>: MPA-resistant IMPDH2 of <italic toggle="yes">Meyerozyma guilliermondii</italic>; ScIMPDH2-MPA<sup>R</sup>: MPA-resistant IMPDH2 of <italic toggle="yes">Saccharomyces cerevisiae</italic>; ScIMPDH3-MPA<sup>S</sup>: MPA-sensitive IMPDH3 of <italic toggle="yes">Saccharomyces cerevisiae</italic>; CaIMPDH-MPA<sup>R</sup>: IMPDH of a MPA-resistant strain of <italic toggle="yes">Candida albicans</italic>; CaIMPDH-MPA<sup>S</sup>: MPA-sensitive IMPDH of <italic toggle="yes">Candida albicans</italic>; PbIMPDHA-MPA<sup>R</sup>: MPA-resistant IMPDH-A of <italic toggle="yes">Penicillium brevicompactum</italic>; AnIMPDH-MPA<sup>S</sup>: MPA-sensitive IMPDH of <italic toggle="yes">Aspergillus nidulans</italic>.</p></caption><graphic xlink:href="jof-07-00849-g001a" position="float"/><graphic xlink:href="jof-07-00849-g001b" position="float"/><graphic xlink:href="jof-07-00849-g001c" position="float"/><graphic xlink:href="jof-07-00849-g001d" position="float"/></fig><table-wrap position="float" id="jof-07-00849-t001"><object-id pub-id-type="pii">jof-07-00849-t001_Table 1</object-id><label>Table 1</label><caption><p>Characteristics of the 10 solid organ transplant recipients treated with mycophenolic acid.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Patient Code</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Underlying Conditions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post-Transplantation Period (Duration in Months) <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Date of PCP Diagnosis (Year)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Examined Specimensfor PCP Diagnosis </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results of<break/><italic toggle="yes">P. jirovecii</italic><break/>Detection in<break/>Pulmonary<break/>Specimens Using<break/>Microscopy <sup>b</sup>/PCR <sup>c</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PCP Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">T1</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">73</td><td align="center" valign="middle" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Death</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T2</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">57</td><td align="center" valign="middle" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Death</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T3</td><td align="center" valign="middle" rowspan="1" colspan="1">HTR</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T4</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">39</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T5</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">33</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP <sup>d</sup> Atovaquone + corticosteroids <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">Death</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T6</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">43</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Death</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T7</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">151</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">Sputum</td><td align="center" valign="middle" rowspan="1" colspan="1">ND/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T8</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">49</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T9</td><td align="center" valign="middle" rowspan="1" colspan="1">RTR</td><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RTR + LTR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">216</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sputum</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND/+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Death</td></tr></tbody></table><table-wrap-foot><fn><p>The male/female ratio was 7/3, the median age was 65 (range 55&#x02013;78); Age and sex were not indicated in extenso, since it could be identifiable patient information; BAL: bronchoalveolar lavage; ND: not determined; +/&#x02212;: positive/negative; HTR, heart transplant recipient; LTR, liver transplant recipient; RTR: renal transplant recipient; SMX-TMP: sulfamethoxazole-trimethoprim. <sup>a</sup> The post-transplantation period is also the duration of MPA exposure. <sup>b</sup> Microscopic detection of <italic toggle="yes">P. jirovecii</italic> was performed using Wright&#x02013;Giemsa staining and, until December 2017, an immunofluorescence assay (MonofluoKit <italic toggle="yes">P. jirovecii</italic>, Bio-Rad). <sup>c</sup> PCR detection of <italic toggle="yes">P. jirovecii</italic> was performed using a real-time PCR assay, targeting the mitochondrial large subunit ribosomal RNA gene [<xref rid="B15-jof-07-00849" ref-type="bibr">15</xref>]. <sup>d</sup> First-line treatment. <sup>e</sup> Second-line treatment.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jof-07-00849-t002"><object-id pub-id-type="pii">jof-07-00849-t002_Table 2</object-id><label>Table 2</label><caption><p>Characteristics of the 16 control patients without prior exposure to mycophenolic acid.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Patient Code</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Underlying Conditions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Date of PCP Diagnosis (Year)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Examined Specimensfor PCP Diagnosis</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Results of<break/><italic toggle="yes">P. jirovecii</italic><break/>Detection in<break/>Pulmonary<break/>Specimens Using<break/>Microscopy <sup>a</sup>/PCR <sup>b</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PCP Treatment</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">C1</td><td align="center" valign="middle" rowspan="1" colspan="1">HM<break/>(mantle cell lymphoma)</td><td align="center" valign="middle" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C2</td><td align="center" valign="middle" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP </td><td align="center" valign="middle" rowspan="1" colspan="1">Death</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C3</td><td align="center" valign="middle" rowspan="1" colspan="1">HM<break/>(B cell lymphoma)</td><td align="center" valign="middle" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" rowspan="1" colspan="1">Sputum</td><td align="center" valign="middle" rowspan="1" colspan="1">ND/+</td><td align="center" valign="middle" rowspan="1" colspan="1">Atovaquone</td><td align="center" valign="middle" rowspan="1" colspan="1">Death</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C4</td><td align="center" valign="middle" rowspan="1" colspan="1">IS <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C5</td><td align="center" valign="middle" rowspan="1" colspan="1">Cancer<break/>(glioblastoma)</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">Sputum</td><td align="center" valign="middle" rowspan="1" colspan="1">ND/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C6</td><td align="center" valign="middle" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" rowspan="1" colspan="1">2016</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C7</td><td align="center" valign="middle" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" rowspan="1" colspan="1">2017</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP </td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C8</td><td align="center" valign="middle" rowspan="1" colspan="1">Cancer<break/>(bronchial carcinoma)</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C9</td><td align="center" valign="middle" rowspan="1" colspan="1">IS <sup>d</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C10</td><td align="center" valign="middle" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">Sputum</td><td align="center" valign="middle" rowspan="1" colspan="1">ND/+</td><td align="center" valign="middle" rowspan="1" colspan="1">Atovaquone</td><td align="center" valign="middle" rowspan="1" colspan="1">Death </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C11</td><td align="center" valign="middle" rowspan="1" colspan="1">HM<break/>(acute myeloid leukemia)</td><td align="center" valign="middle" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">-/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Death</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C12</td><td align="center" valign="middle" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C13</td><td align="center" valign="middle" rowspan="1" colspan="1">Cancer<break/>(breast adenocarcinoma)</td><td align="center" valign="middle" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C14</td><td align="center" valign="middle" rowspan="1" colspan="1">HIV</td><td align="center" valign="middle" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C15</td><td align="center" valign="middle" rowspan="1" colspan="1">Cancer<break/>(bronchial carcinoma)</td><td align="center" valign="middle" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" rowspan="1" colspan="1">Sputum</td><td align="center" valign="middle" rowspan="1" colspan="1">ND/+</td><td align="center" valign="middle" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" rowspan="1" colspan="1">Recovery</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IS <sup>e</sup>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BAL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">+/+</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SMX-TMP</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recovery</td></tr></tbody></table><table-wrap-foot><fn><p>The male/female ratio was 12/4, the median age was 60 (range 30&#x02013;89); age and sex were not indicated in extenso since it could be identifiable patient information; BAL: bronchoalveolar lavage; ND: not determined; +/&#x02212;: positive/negative; HM: haematological malignancy; HIV: human immunodeficiency virus; IS: immunosuppressive therapy; SMX-TMP: sulfamethoxazole-trimethoprim. <sup>a</sup> Microscopic detection of <italic toggle="yes">P. jirovecii</italic> was performed using Wright&#x02013;Giemsa staining and, until December 2017, an immunofluorescence assay (MonofluoKit <italic toggle="yes">P. jirovecii</italic>, Bio-Rad). <sup>b</sup> PCR detection of <italic toggle="yes">P. jirovecii</italic> was performed using a real-time PCR assay, targeting the mitochondrial large subunit ribosomal RNA gene [<xref rid="B15-jof-07-00849" ref-type="bibr">15</xref>]. <sup>c</sup> Azathioprine, anti-TNF&#x003b1; and corticosteroids treatments for Crohn&#x02019; disease. <sup>d</sup> Methotrexate and corticosteroids treatments Horton&#x02019;s disease. <sup>e</sup> Methotrexate treatment for psoriasis.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jof-07-00849-t003"><object-id pub-id-type="pii">jof-07-00849-t003_Table 3</object-id><label>Table 3</label><caption><p>Single nucleotide polymorphisms of <italic toggle="yes">Pneumocystis jirovecii impdh</italic> gene in 10 solid organ transplant recipients with prior exposure to mycophenolic acid and 16 control patients which were not SOT recipients and had no prior exposure to MPA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Patient Code</th><th colspan="9" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Nucleotide Position (bp)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">IMPDH</italic> Allele</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">914</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1020</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1269</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1329</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1737</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1754</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1850</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1952</th></tr></thead><tbody><tr><td colspan="11" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">SOT recipients </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T1</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T2</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T3</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A/G <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH1 + IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T4</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T5</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T6</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T7</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T8</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T9</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A/G <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-1 + IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T10</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td colspan="11" align="center" valign="middle" rowspan="1">Control patients </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C1</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-1</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C2</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G/A<sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-5 + IMPDH-6</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C3</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-2</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C4</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-2</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C5</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-5</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C6</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-4</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C7</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">C/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-2 + IMPDH-5</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C8</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-1+ IMPDH-5</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C9</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-2</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C10</td><td align="center" valign="middle" rowspan="1" colspan="1">G/T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-5 + IMPDH-7</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C11</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-5</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C12</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">C/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-2 + IMPDH-5</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C13</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A/G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-5 + IMPDH-8</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C14</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">A/G <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">C/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-1 + IMPDH-4</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C15</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">C/T <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">G/A <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-1 + IMPDH-2</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C/T <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A/T <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A/G <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C/T <sup>a</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-4 + IMPDH-5</italic>
</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Two nucleotides were identified at this position on sequence electropherograms.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jof-07-00849-t004"><object-id pub-id-type="pii">jof-07-00849-t004_Table 4</object-id><label>Table 4</label><caption><p><italic toggle="yes">Pneumocystis jirovecii IMPDH</italic> alleles defined in the present study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="9" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Nucleotide Positions (bp)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">IMPDH</italic> Allele</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">914</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1020</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1269</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1329</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1737</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1754</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1850</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1952</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-1</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-2</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-3</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-4</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-5</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-6</italic>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">A</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">C</td><td align="center" valign="middle" rowspan="1" colspan="1">T</td><td align="center" valign="middle" rowspan="1" colspan="1">G</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-7</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">IMPDH-8</italic>
</td></tr></tbody></table></table-wrap></floats-group></article>